Related Experiment Video

Updated: Oct 9, 2025

Cardiopulmonary Bypass in a Mouse Model: A Novel Approach
08:08

Cardiopulmonary Bypass in a Mouse Model: A Novel Approach

Published on: September 22, 2017

11.2K

Pediatric Cardio-Oncology Medicine: A New Approach in Cardiovascular Care

Hugo R Martinez1, Gary S Beasley1, Jason F Goldberg1

  • 1Division of Pediatric Cardiology, The Heart Institute at Le Bonheur Children's Hospital, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

Children (Basel, Switzerland)
|December 24, 2021
PubMed

Insights

Pediatric cancer survival is improving due to advanced treatments and supportive care. This study outlines a collaborative approach to cardiovascular care for children with cancer, addressing limited pediatric cardio-oncology guidelines.

Area of Science:

  • Pediatric Oncology
  • Cardiology
  • Cardio-Oncology

Background:

  • Significant improvements in survival rates for pediatric cancer patients.
  • Advancements in cancer treatment modalities and multidisciplinary supportive care.
  • Recognized need for specialized cardiovascular care in pediatric oncology.

Purpose of the Study:

  • To address the challenge of expanding oncology disciplines and limited pediatric cardio-oncology guidelines.
  • To develop risk-stratification systems for surveillance and therapeutic support.
  • To describe a collaborative approach for comprehensive cardiovascular care in pediatric oncology.

Main Methods:

  • Describing a collaborative model for cardiovascular care.
  • Focusing on children and young adults with oncology diseases.
  • Developing risk-stratification systems for patient management.

Main Results:

  • Establishing a framework for comprehensive cardiovascular care in pediatric oncology.
  • Proposing risk-stratification to guide surveillance and support.
  • Highlighting the importance of a multidisciplinary approach.

Conclusions:

  • Collaboration in pediatric cardio-oncology is crucial for high-quality patient care.
  • Developing specialized care models enhances outcomes for young cancer patients.
  • Future generations will benefit from advancements in pediatric cardio-oncology.

Keywords:
cardiovascular healthcareearly detectionindividualization of therapiesoncology therapiespediatric cardiology-oncologypredictive healthcare models

More Related Videos

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

6.8K
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

950

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
60
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
341
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
12
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
156
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
59